check

Commercial Friction Tax Audit

Uncover your Hidden EBITDA Vulnerabilities in 2 minutes. Quantify the operational drag impacting your leaders, pipeline, and margins.

What you will get upon completion:

  • Your confidential customized "Commercial Drag Metric" within 48 hours that exposes the exact financial cost of inaction, payroll waste, and deal stall—giving you the hard numbers and supporting research needed to justify immediate action.

  • A Complimentary 15-min diagnostic debrief:  A 1:1 Peer session with Rhonda Petit to review your risk profile across the human, commercial, and financial balance sheets.

  • Actionable Value-Stabilization Options: Immediate targeted strategies to remove friction, accelerate funnel velocity, & protect key talent to keep your 3-year valuation roadmap on track.

  •  Supporting data research for the Friction Tax expense

Click the button below to start. There are 6 multiple choice questions that take approximately 2 minutes to complete.

Start

Question 1 of 9

Q1 (Key Person Dependency):  What percentage of your company's critical 12-month R&D, clinical, or commercial milestones depend primarily on 1 to 3 key leaders without functional redundancy or secondary backup?

 

Consider your top functional leads (VP R&D, VP Medical/Clinical, VP Commercial). If 1 or 2 key leaders were unavailable for 30 days, what portion of your strategic roadmap would stall?

 

A

1=very unlikely (1 Pt - Fully distributed execution; strong leadership bench)

B

2=unlikely (2 Pts - Minor concentration; key functions have secondary coverage)

C

3= Moderate Risk (3 Pts - Critical launches tied to specific individuals)

D

4=Likely (4 Pts - High dependency; multi-role strain on functional VPs)

E

5= Very likely (5 Pts - Severe vulnerability; single-point-of-failure across core initiatives)

Question 2 of 9

Q2 (Talent Flight Risk & Retention):

 

Following recent acquisitions, restructurings, or rapid scaling, how likely is it that top-tier talent is actively exploring outside opportunities?

 

Focus specifically on high performers and subject-matter experts (R&D, Medical/Clinical, Commercial) whose departure directly impacts enterprise valuation or execution timeline.

A

1=very unlikely (1 Pt - Key talent fully incentivized & aligned)

B

2=unlikely (2 Pts - Low risk; minor gaps in succession)

C

3= Moderate risk (3 Pts - Moderate risk; key managers unhedged)

D

4= likely (4 Pts - High risk; widespread vulnerability to recruiter poaching)

E

5= very likely (5 Pts - Severe vulnerability; critical talent actively unanchored)

Question 3 of 9

Q3 (Pipeline Velocity): Approximately what percentage of your active, high-value main street market pipeline stalls or ends in 'No Decision' after the initial value proposition or proof-of-concept phase (Stages 3–4) or extended buyer paralysis?

 

Think of your mid-to-late pipeline stages (Stage 3: Value Prop / Stage 4: Proof of Concept). Where are deals losing momentum?

A

1 – Negligible (< 10% loss rate due to paralysis)

B

2 – Low (10–20% stalled/lost to no decision)

C

3 – Moderate (21–35% stalled/lost to no decision)

D

4 – High (36–50% stalled/lost to no decision)

E

5 – Severe (> 50% stalled/lost to no decision)

Question 4 of 9

Q4 (Cross-Functional Drag):  How much internal friction slows collaboration between commercial, medical affairs, and operation teams in executing the value creation plan?

 

Observe how Commercial, Medical Affairs, and Ops interact: Are they pushing key decisions forward with radical candor, deferring them out of paralysis (Freeze/Avoidance), or fighting for territorial dominance?

A

1= Almost none (1 Pt - Smooth cross-functional execution)

B

2=Minimal Friction (2 Pts - Rare occasions of friction)

C

3=Moderate friction (3 Pts - Frequent avoidance/artificial harmony)

D

4=High Friction (4 Pts - Frequent decision paralysis/stagnation)

E

5=Severe Friction (5 Pts - Active political warfare or constant escalation)

Question 5 of 9

Q5 (Organizational Strain & Health Claims):  What percentage increase in stress-related absenteeism, executive medical leaves, or self-funded healthcare claims cost has your organization experienced over the past budget cycle?

 

Look at your recent board updates or HR dashboard: Are health benefits costs, employee engagement scores, or stress-related leaves trending in a way that threatens budget or team capacity?

A

Less than 5% increase (1 Pt - Well-managed energy & low health risk)

B

5% – 9% increase (2 Pts - Normal operational baseline)

C

10% – 15% increase (3 Pts - Moderate fatigue & noticeable claim growth)

D

16% – 25% increase (4 Pts - High strain; escalating healthcare tax & absenteeism)

E

Over 25% increase (5 Pts - Severe burnout tax; acute operational & benefits drain)

Question 6 of 9

Q6 (Execution Cadence & Milestone Slippage):  How often are strategic milestones or quarterly deadlines slipping because of operational firefighting?

 

Review your past 12 months of board decks: How often are strategic initiatives pushed into the next quarter because daily operational friction or urgent fires took over?

A

1= rarely (1 Pt - Optimized Cadence; predictable execution)

B

2=occasional drift (2 Pts - Minor Drift; quarter-end compression)

C

3=Moderate Slippage (3 Pts -Frequent milestone roll-overs)

D

4=High Slippage (4 Pts - Chronic deadline slippage across teams)

E

5=Consistently (5 Pts - Severe Breakdown; perpetual firefighting with minimal strategic delivery)

Question 7 of 9

Q7:  What is your average deal size in your funnel?

A

1= $500- $2500

B

2= $2500-$10,000

C

3 = $11,000-$25,000

D

4= $26,000-$50,000

E

5= $51,000-$100,000

F

6= $101,000-$250,000

G

7= $251,000-$500,000+

Question 8 of 9

Q8: What is the average salary baseline for your commercial team leaders(i.e. $150,000/yr)

Question 9 of 9

Q9:  How many weekly hours are lost to resolving internal conflict/escalations or sub-optimal performance?  

Confirm and Submit